SEP 10, 2020 10:20 PM PDT

Researchers Will Be Allowed To Use State-Licensed Cannabis for Research

WRITTEN BY: Angela Dowden

Cannabis researchers in the U.S. have often had their research efforts frustrated by the difficulties in being able to access marijuana and marijuana products. The problem has been that privately grown cannabis—even from state-licensed and compliant manufacturers—was not allowed in FDA-approved clinical trials. Instead, investigators were only allowed to obtain whole-plant cannabis from a single source: the University of Mississippi, which since 1968 was the only federally licensed source of cannabis cultivated for research purposes.

The good news is that change is afoot and quickly, following a September 9, 2020 vote by members of the House Energy and Commerce Committee to amend Congressman Earl Blumenauer’s HR 3797 bill: “The Marijuana Research Act of 2019”. The amended legislation expedites an approval process for newly-allowed federal cultivation applicants, and provides scientists with the option to utilize products manufactured by these state-licensed sources, not just the old official source.

 “The bipartisan support of our legislation in [this] committee mark-up is an important step in removing unnecessary barriers to medical cannabis research and ensuring that patients, clinicians, and consumers can fully understand the benefits and risks of cannabis,” Rep. Blumenauer said.

Deputy Director Paul Armentano from the National Organization for the Reform of Marijuana Laws (NORML) added that the new bill will “facilitate and expedite clinical cannabis research in the United States and provide important data regarding the safety and efficacy of real-world products.”

He added: “Rather than compelling scientists to access marijuana products of questionable quality manufactured by a limited number of federally licensed producers, federal regulators should allow investigators to access the cannabis and cannabis-infused products that are currently being produced in the legal marketplace by the multitude of state-sanctioned growers and retailers”.

Scientists have consistently criticized the poor quality of the University of Mississippi’s plants, which they say fail to accurately reflect the varieties of marijuana commercially available. For example scientists have only been able to select six varieties of pre-rolled cannabis cigarettes—none of which possess THC concentrations above seven percent—from the federal government’s marijuana menu, and tinctures and concentrates have not been available for clinical study at all.

Source: NORML

About the Author
  • I'm a Journalist and author with many year's experience of writing for both a consumer and professional audience, mostly on nutrition, health and medical prescribing. My background is food science and I'm a registered nutritionist.
You May Also Like
DEC 29, 2020
Immunology
Cancer-Killing Viruses Enter in Stealth Mode, Penetrate Immune Barrier
DEC 29, 2020
Cancer-Killing Viruses Enter in Stealth Mode, Penetrate Immune Barrier
Viruses that when administered to patients preferentially attack and kill cancer cells, leaving normal tissues unscathed ...
JAN 05, 2021
Cell & Molecular Biology
Brown Fat Appears to Protect Against Disease
JAN 05, 2021
Brown Fat Appears to Protect Against Disease
Not all fat is the same. White fat is what we're usually thinking of when we think of flabby tissue that stores excess c ...
JAN 07, 2021
Health & Medicine
How Cannabis Might Help Fibromyalgia
JAN 07, 2021
How Cannabis Might Help Fibromyalgia
Fibromyalgia affects as many as 4 million adults in America  (2 percent of the adult population) and is a debilitat ...
JAN 17, 2021
Immunology
A Single Dose Nanoparticle Vaccine for COVID-19
JAN 17, 2021
A Single Dose Nanoparticle Vaccine for COVID-19
In the race for finding the right vaccine for the COVID-19 pandemic, a new vaccine candidate emerged. Researchers at Sta ...
JAN 17, 2021
Microbiology
Gut Microbes May Play a Role in Anorexia
JAN 17, 2021
Gut Microbes May Play a Role in Anorexia
Eating disorders like anorexia nervosa and bulimia nervosa are illnesses that involve serious disturbances in eating beh ...
JAN 20, 2021
Microbiology
Cannabis Compound Could Lead to New Class of Antibiotics
JAN 20, 2021
Cannabis Compound Could Lead to New Class of Antibiotics
For the first time, a synthetic version of a non-psychoactive molecule found in marijuana has been shown to kill pathoge ...
Loading Comments...